Andrew Phimister, VP of CMC
Professional Overview
Andrew Phimister is an accomplished pharmaceutical executive with over 20 years of experience in drug development, manufacturing, and operations. As the Vice President of CMC (Chemistry, Manufacturing, and Controls) at Alterome Therapeutics, Inc., he oversees the company's critical manufacturing and quality control processes, ensuring the successful development and commercialization of innovative therapeutics. With a strong technical background and proven leadership skills, Phimister also serves as a Principal at Seaview Pharma Solutions, where he provides strategic consulting to biotechnology and pharmaceutical organizations.
Experience Summary
Current Role
As the Vice President of CMC at Alterome Therapeutics, Inc., Phimister is responsible for leading the company's CMC strategy, ensuring the seamless integration of manufacturing and quality systems to support the advancement of the organization's drug pipeline. He has been instrumental in establishing robust quality control measures and streamlining production processes, enabling Alterome to achieve critical milestones and deliver on its clinical development objectives.
Career Progression
Prior to his current role, Phimister held various leadership positions in the pharmaceutical industry, including serving as the Vice President of Drug Product at Alterome Therapeutics, Inc., and the Vice President of CMC and Technical Operations at Asteroid Therapeutics, Inc. He also has extensive experience in business development, having served as the Director of Business Development at WuXi AppTec, where he played a key role in expanding the company's global footprint and securing strategic partnerships.
Phimister began his career as a Scientist at Chiron Corporation and an Associate at Incyte Genomics, where he honed his technical expertise in biotechnology and pharmaceutical research. He later joined Novartis as a Senior Fellow, contributing to the development and manufacturing of innovative therapies.
Academic Background
Phimister holds a Bachelor of Science degree in Biochemistry from the University of California, Berkeley, and a Ph.D. in Molecular Biology from the University of Washington.
Areas of Expertise
- CMC strategy and execution
- Pharmaceutical manufacturing and quality control
- Regulatory compliance and submissions
- Technical operations management
- Business development and strategic partnerships
- Cross-functional team leadership and collaboration
Professional Impact
Throughout his career, Phimister has played a pivotal role in advancing the development and commercialization of several successful pharmaceutical products. His technical expertise, coupled with his strong leadership and strategic decision-making abilities, have enabled him to drive tangible results and positively impact the industry.
Conclusion
With his extensive experience, technical acumen, and proven track record of success, Andrew Phimister is well-positioned to continue driving innovation and propelling the growth of Alterome Therapeutics and Seaview Pharma Solutions. His strategic leadership and commitment to excellence make him a valuable asset in the pharmaceutical industry.
